Tychan, a Singapore-based clinical-stage biotechnology company, is initiating Phase 1 clinical trials to evaluate TY027, the first novel monoclonal antibody (mAb) that specifically targets SARS-CoV-2, the virus that causes COVID-19.
Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors.
Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.
Researchers screening wastewater in Massachusetts for the novel coronavirus found more traces of the pathogen than expected given the number of confirmed cases in the area.
As the novel coronavirus continues to spread and devastate communities, the United States is still struggling to do enough testing to understand the true scale of the epidemic. Now, researchers around the country are looking for new tools to help track how the virus is spreading. Testing your sewage may be one way.
Study shows that a simple urine test can reveal the presence of lung cancer in mice.
A group of researchers are launching clinical trials for a drug they hope can treat respiratory failure in COVID-19 patients more effectively.
MIT biochemists can trap and visualize an enzyme as it becomes active — an important development that may aid in future drug development.
MIT chemists are testing a protein fragment that may inhibit coronaviruses’ ability to enter human lung cells.
Repurposing a drug used for blood clots may help Covid-19 patients in danger of respiratory failure, researchers suggest.
An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.
Monitoring the plant hormone ethylene could reveal when fruits and vegetables are about to spoil.
A new approach reveals how different tissues contribute to inflammatory diseases such as ulcerative colitis.
Scientists discover the structure of an enzyme, found in the human gut, that breaks down a component of collagen.
Heads John and Ellen Essigmann, as well as Associate Head Steven Hall, to depart from Simmons.
In the United States, there are thousands of industrial sites contaminated by the irresponsible disposal of chemical waste. The higher than expected frequency of cancer cases near these sites has caused alarm, since many of the chemical contaminants found at these sites have been linked to the development of long-term health problems, including cancer. As leaders of the Massachusetts Institute of Technology Superfund Research Program, Dr Jennifer Kay (Research Scientist and Research Translation Director) and Professor Bevin Page Engelward (Program Director) are using their expertise to investigate the genetic factors that influence susceptibility to adverse health outcomes following exposure to environmental chemicals.
Study tracks pollution from state to state in the 48 contiguous United States.
Research underscores infection is not a common hospital transmission.
The protective substance is an important barrier between a woman’s body and the environment. Here’s how researchers are using it to understand health.
Study suggests noninvasive spectroscopy could be used to monitor blood glucose levels. Read more
Developed by MIT chemists; A new test using specific liver cells can quickly detect cancer-causing DNA damage. Read more